
Cancer Care
Research Domain: Cancer Care
The Cancer Care research domain targets the comprehensive healthcare services, treatments, and support provided to individuals diagnosed with cancer. It encompasses various aspects including prevention, diagnosis, treatment planning and delivery, supportive care, and survivorship programs to improve patients’ well-being and outcomes.
St. Mary’s Research Centre scientists have identified the following priority research themes:
-
Community Oncology: Cancer treatment and care provided within local communities or non-specialised healthcare settings.
-
Patient Reported Outcome Measurements and Follow-Up: Collecting feedback from patients about their symptoms, experiences, and quality of life during and after cancer treatment to inform their ongoing care.
-
Screening and Prevention: Efforts to detect cancer at an early stage or prevent its occurrence through measures like regular screenings and lifestyle changes.
-
Supported Self-Care for Patients and Caregivers: Empowering patients and their caregivers with information and resources to manage aspects of cancer care on their own.
-
Cancer Care Outcomes: Assessing the results and impact of cancer treatments and interventions on patients' health and well-being.
-
Oncology Clinical Trials: Conducted to investigate new treatments, drugs, therapies, and interventions for cancer patients. These trials are designed to evaluate the safety and effectiveness of these innovations in a controlled and systematic manner before they are widely adopted as standard treatments. Clinical trials in oncology are a crucial part of advancing our understanding of cancer and improving cancer care.
Oncology Clinical Trials
The Oncology Clinical Trials research theme stands as a paramount priority, playing a pivotal role in advancing cancer research not only within our immediate community but also on a broader national scale. These trials serve as a platform to introduce innovative and cutting-edge treatments to patients, offering a pathway for researchers to expand the current body of knowledge in cancer care. In essence, the support provided through oncology clinical trials contributes to the development of more effective and targeted therapies, ensuring the well-being of our communities.
